Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Charpentier

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Diabetes/Metabolism Research and Reviews|September 27, 2002
Oral combination therapy for type 2 diabetesGuillaume Charpentier
Diabetes, Obesity & Metabolism|June 25, 2025
Emotional distress as a therapeutic target against persistent poor glycaemic control in subjects with type 1 diabetes: A systematic reviewSylvia Franc, Guillaume Charpentier
Diabetes & Metabolism|October 19, 2021
Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launchCoralie Amadou, Sylvia Franc, Erik Huneker, et al.
Drugs|March 11, 2006
Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated?Guillaume Charpentier, Jean-Pierre Riveline, Dured Dardari, et al.
Acta Diabetologica|March 10, 2018
Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop studyPierre Yves Benhamou, Erik Huneker, Sylvia Franc, et al.
Diabetes & Metabolism|October 20, 2023
Impact of chronic emotions and psychosocial stress on glycemic control in patients with type 1 diabetes. Heterogeneity of glycemic responses, biological mechanisms, and personalized medical treatmentSylvia Franc, Samir Bensaid, Pauline Schaepelynck, et al.
Diabetes, Obesity & Metabolism|October 1, 2020
Patients with highly unstable type 1 diabetes eligible for islet transplantation can be managed with a closed-loop insulin delivery system: A series of N-of-1 randomized controlled trialsPierre-Yves Benhamou, Sandrine Lablanche, Anne Vambergue, et al.
Journal of Diabetes Science and Technology|October 18, 2021
Hybrid Closed-Loop Control with Ultrarapid Lispro Compared with Standard Insulin Aspart and Faster Insulin Aspart: An In Silico StudySylvain Lachal, Yousra Tourki, Sylvia Franc, et al.
Diabetes/Metabolism Research and Reviews|September 9, 2010
Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitusAndré J Scheen, Guillaume Charpentier, Carl Johan Ostgren, et al.
Journal of Diabetes Science and Technology|May 28, 2024
Insulin Requirements According to Sex and Weight in a Population of 9036 Adult Persons With Type 1 Diabetes Using Closed-Loop Insulin DeliveryHocine Lebbad, Chesner Desir, Aurélien Vesin, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Diabetes/Metabolism Research and Reviews|September 27, 2002
Oral combination therapy for type 2 diabetesGuillaume Charpentier
Diabetes, Obesity & Metabolism|June 25, 2025
Emotional distress as a therapeutic target against persistent poor glycaemic control in subjects with type 1 diabetes: A systematic reviewSylvia Franc, Guillaume Charpentier
Diabetes & Metabolism|October 19, 2021
Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launchCoralie Amadou, Sylvia Franc, Erik Huneker, et al.
Drugs|March 11, 2006
Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated?Guillaume Charpentier, Jean-Pierre Riveline, Dured Dardari, et al.
Acta Diabetologica|March 10, 2018
Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop studyPierre Yves Benhamou, Erik Huneker, Sylvia Franc, et al.
Diabetes & Metabolism|October 20, 2023
Impact of chronic emotions and psychosocial stress on glycemic control in patients with type 1 diabetes. Heterogeneity of glycemic responses, biological mechanisms, and personalized medical treatmentSylvia Franc, Samir Bensaid, Pauline Schaepelynck, et al.
Diabetes, Obesity & Metabolism|October 1, 2020
Patients with highly unstable type 1 diabetes eligible for islet transplantation can be managed with a closed-loop insulin delivery system: A series of N-of-1 randomized controlled trialsPierre-Yves Benhamou, Sandrine Lablanche, Anne Vambergue, et al.
Journal of Diabetes Science and Technology|October 18, 2021
Hybrid Closed-Loop Control with Ultrarapid Lispro Compared with Standard Insulin Aspart and Faster Insulin Aspart: An In Silico StudySylvain Lachal, Yousra Tourki, Sylvia Franc, et al.
Diabetes/Metabolism Research and Reviews|September 9, 2010
Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitusAndré J Scheen, Guillaume Charpentier, Carl Johan Ostgren, et al.
Journal of Diabetes Science and Technology|May 28, 2024
Insulin Requirements According to Sex and Weight in a Population of 9036 Adult Persons With Type 1 Diabetes Using Closed-Loop Insulin DeliveryHocine Lebbad, Chesner Desir, Aurélien Vesin, et al.
Pageof 12